United States - Trials & Appeals & Compensation - Federal Circuit PTAB Appeal Statistics For February And March 2024
In both February and March, the Federal Circuit affirmed a similar percentage of appeals from PTAB post-grant proceedings.
Stay updated with breaking news from Pasteur Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In both February and March, the Federal Circuit affirmed a similar percentage of appeals from PTAB post-grant proceedings.
Defining Indefiniteness: When Are Claim Limitations Contradictory? In Maxell, Ltd., v. Amperex Technology Limited, Appeal No. 23-1194, the Federal Circuit held that two...
The results-effective variable doctrine is a caselaw principle where prior art disclosing the "general conditions of a claim" invokes a presumption of obviousness...
In Pfizer Inc. vs. Sanofi Pasteur Inc., the Federal Circuit upheld the Patent Trial and Appeal Board decision to invalidate portions of Pfizer's pneumococcal vaccine patent on the grounds of...
In Pfizer Inc. vs. Sanofi Pasteur Inc., the Federal Circuit upheld the Patent Trial and Appeal Board (PTAB) decision to invalidate portions of Pfizer's pneumococcal...